Inhibition of lipid peroxide formation in mitochondria and fatty acid emulsions by 2,6-bis-(diethanolamino)-4,8-dipiperidino-pyrimido-(5,4-d)-pyimidine.
D000818:Animals; D001205:Ascorbic Acid / Q000037:antagonists & inhibitors; D003545:Cysteine / Q000037:antagonists & inhibitors; D003864:Depression, Chemical; D004176:Dipyridamole / Q000008:administration & dosage / Q000494:pharmacology*; D004655:Emulsions; D005227:Fatty Acids / Q000032:analysis*; D005978:Glutathione / Q000037:antagonists & inhibitors; D066298:In Vitro Techniques; D007501:Iron / Q000037:antagonists & inhibitors; D008055:Lipids / Q000037:antagonists & inhibitors*; D008930:Mitochondria, Liver / Q000032:analysis / Q000187:drug effects / Q000378:metabolism* / Q000528:radiation effects; D010084:Oxidation-Reduction; D010101:Oxygen Consumption / Q000187:drug effects*; D010545:Peroxides / Q000037:antagonists & inhibitors* / Q000096:biosynthesis; D010743:Phospholipids / Q000037:antagonists & inhibitors*; D051381:Rats; D013268:Stimulation, Chemical; D014466:Ultraviolet Rays
D004655:Emulsions; D005227:Fatty Acids; D008055:Lipids; D010545:Peroxides; D010743:Phospholipids; D004176:Dipyridamole; D007501:Iron; D005978:Glutathione; D003545:Cysteine; D001205:Ascorbic Acid